New Stock News | Health 160 passes the Hong Kong Stock Exchange hearing with an average of 3.3 million monthly active users on the platform.
According to the disclosure of the Hong Kong Stock Exchange on September 4, Healthy 160 International Limited (hereinafter referred to as "Healthy 160") passed the listing hearing on the main board of the Hong Kong Stock Exchange, with Shenwan Hongyuan Hong Kong and Qingke Capital as its joint sponsors.
According to the disclosure from the Hong Kong Stock Exchange on September 4th, Healthy 160 International Limited (hereinafter referred to as Healthy 160) has undergone a listing hearing on the main board of the Hong Kong Stock Exchange, with Shenwan Hongyuan Group Hong Kong and Qingke Capital acting as its joint sponsors.
According to the prospectus, Healthy 160 is an experienced distributor of health products from China Meheco Group and a leading digital healthcare service provider. The company provides customers with various medical and health products, as well as comprehensive digital healthcare solutions. Through wholesale and retail models, it offers a range of high-quality medical and health products to meet the diverse needs of customers. Additionally, the company provides digital healthcare solutions through an online healthcare service platform - the Healthy 160 platform, empowering various participants in the healthcare industry chain (including corporate clients, healthcare institutions, healthcare workers, individual users, and third-party merchants) to drive the digital transformation of the healthcare industry in China.
In providing digital healthcare solutions, the company has developed the Healthy 160 platform, which effectively connects healthcare institutions, healthcare workers, and individual users by integrating online and offline healthcare services. The platform offers a variety of medical and healthcare services, including serious medical and consumer healthcare services. The company employs effective monetization strategies in its digital healthcare solutions to generate revenue from the various platform participants, forming a significant source of income for the company. Based on Frost & Sullivan data, the company is the largest digital healthcare service platform in the digital healthcare industry in China by various metrics such as the number of registrations through the platform by 2024, the number of partner hospitals as of December 31, 2024, the number of tertiary hospitals partnering as of December 31, 2024, and the number of healthcare workers accessing the platform as of December 31, 2024.
As of March 31, 2025, the company's platform has connected over 44,600 healthcare institutions since its inception, including over 14,400 hospitals (including 3,430 tertiary hospitals) and over 30,200 grassroots healthcare institutions. As of the same date, over 6,800 private institutions among the company's partner healthcare institutions primarily provide consumer healthcare services such as dental, optical, and medical check-up services on the platform.
As of the same date, the company has established partnerships with over 902,300 healthcare workers since its inception, including approximately 46,200 registered doctors. Additionally, the platform has a large user base, with 55.2 million registered individual users as of March 31, 2025. Furthermore, the platform recorded an average of 3.3 million monthly active users in the three months ending on March 31, 2025.
Furthermore, the accumulation of over 5.6 million user comments highlights the active participation and positive interaction of users on the company's platform. The multi-dimensional communication and interaction reflect the robustness of the company's healthcare service network on the platform.
Financially, for the periods ending on March 31, 2022, 2023, 2024, and the three months ending on March 31, 2025, the company's revenues were approximately RMB 526 million, RMB 629 million, RMB 621 million, and RMB 100 million respectively; during the same periods, the losses were approximately RMB 120 million, RMB 106 million, RMB 108 million, and RMB 17.128 million respectively.
Related Articles

US Stock Market Move | GameStop Corp. Class A (GME.US) rose by over 5% in Q2 with adjusted net profit of $138 million.

US Stock Market Move | In the field of artificial intelligence, many individual stocks have hit record highs. Oracle Corporation (ORCL.US) is up nearly 43%.

US Stock Market Move | Core Scientific (CORZ.US) rose by over 9%, with a total market value exceeding $4.8 billion.
US Stock Market Move | GameStop Corp. Class A (GME.US) rose by over 5% in Q2 with adjusted net profit of $138 million.

US Stock Market Move | In the field of artificial intelligence, many individual stocks have hit record highs. Oracle Corporation (ORCL.US) is up nearly 43%.

US Stock Market Move | Core Scientific (CORZ.US) rose by over 9%, with a total market value exceeding $4.8 billion.

RECOMMEND

Significant Southbound Capital Inflows into Hong Kong Stocks—Three Investment Directions to Watch
10/09/2025

Heavy-Duty Engine Sales Slide as Weichai Power’s Supplier Payables Near RMB 100 Billion
10/09/2025

U.S. Annual Nonfarm Payroll Revision Misses Expectations with 911,000-Job Cut, Heightening Fed Rate-Cut Pressure
10/09/2025